These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 9400593)
41. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Wyatt LS; Earl PL; Eller LA; Moss B Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4590-5. PubMed ID: 15070762 [TBL] [Abstract][Full Text] [Related]
42. Susceptibility of various cell lines to virulent an attenuated strains of pseudorabies virus at supraoptimal temperature. Golais F; Sabó A; Svobodová J Acta Virol; 1977 Jan; 21(1):25-30. PubMed ID: 15434 [TBL] [Abstract][Full Text] [Related]
43. A study on the susceptibility of minipig kidney (MPK) and rabbit kidney (RK13) cell line cultures to the lapinized Chinese strain of hog cholera virus. Rivero VB; Gualandi GL; Buonavoglia C; Mortarino P Microbiologica; 1988 Oct; 11(4):371-8. PubMed ID: 3063925 [TBL] [Abstract][Full Text] [Related]
44. Mutations in the nsP1 coding sequence of Sindbis virus which restrict viral replication in secondary cultures of chick embryo fibroblasts prepared from aged primary cultures. Rosenblum CI; Scheidel LM; Stollar V Virology; 1994 Jan; 198(1):100-8. PubMed ID: 8259645 [TBL] [Abstract][Full Text] [Related]
45. Modified vaccinia virus Ankara as a vector for suicide gene therapy. Erbs P; Findeli A; Kintz J; Cordier P; Hoffmann C; Geist M; Balloul JM Cancer Gene Ther; 2008 Jan; 15(1):18-28. PubMed ID: 17992203 [TBL] [Abstract][Full Text] [Related]
46. Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene. Laassri M; Meseda CA; Williams O; Merchlinsky M; Weir JP; Chumakov K J Med Virol; 2007 Jun; 79(6):791-802. PubMed ID: 17457926 [TBL] [Abstract][Full Text] [Related]
47. Extracellular vesicles containing virus-encoded membrane proteins are a byproduct of infection with modified vaccinia virus Ankara. Spehner D; Drillien R Virus Res; 2008 Oct; 137(1):129-36. PubMed ID: 18662728 [TBL] [Abstract][Full Text] [Related]
48. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor. Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110 [TBL] [Abstract][Full Text] [Related]
49. SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells. Liu R; Mendez-Rios JD; Peng C; Xiao W; Weisberg AS; Wyatt LS; Moss B PLoS Pathog; 2019 May; 15(5):e1007710. PubMed ID: 31145755 [TBL] [Abstract][Full Text] [Related]
50. Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tian Tan strain. Fang Q; Yang L; Zhu W; Liu L; Wang H; Yu W; Xiao G; Tien P; Zhang L; Chen Z Virology; 2005 May; 335(2):242-51. PubMed ID: 15840523 [TBL] [Abstract][Full Text] [Related]
51. An avian cell line designed for production of highly attenuated viruses. Jordan I; Vos A; Beilfuss S; Neubert A; Breul S; Sandig V Vaccine; 2009 Jan; 27(5):748-56. PubMed ID: 19071186 [TBL] [Abstract][Full Text] [Related]
52. Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity. Kastenmuller W; Drexler I; Ludwig H; Erfle V; Peschel C; Bernhard H; Sutter G Virology; 2006 Jul; 350(2):276-88. PubMed ID: 16595141 [TBL] [Abstract][Full Text] [Related]
56. Recombinant viruses obtained from co-infection in vitro with a live vaccinia-vectored influenza vaccine and a naturally occurring cowpox virus display different plaque phenotypes and loss of the transgene. Hansen H; Okeke MI; Nilssen O; Traavik T Vaccine; 2004 Dec; 23(4):499-506. PubMed ID: 15530698 [TBL] [Abstract][Full Text] [Related]
57. Construction and testing of a novel host-range defective myxoma virus vaccine with the M063 gene inactivated that is non-permissive for replication in rabbit cells. Adams MM; van Leeuwen BH; McFadden G; Kerr PJ Vet Res; 2008; 39(6):60. PubMed ID: 18778680 [TBL] [Abstract][Full Text] [Related]
58. Human tumor growth is inhibited by a vaccinia virus carrying the E2 gene of bovine papillomavirus. Valdez Graham V; Sutter G; José MV; García-Carranca A; Erfle V; Moreno Mendoza N; Merchant H; Rosales R Cancer; 2000 Apr; 88(7):1650-62. PubMed ID: 10738224 [TBL] [Abstract][Full Text] [Related]
59. Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells. Gallego-Gómez JC; Risco C; Rodríguez D; Cabezas P; Guerra S; Carrascosa JL; Esteban M J Virol; 2003 Oct; 77(19):10606-22. PubMed ID: 12970445 [TBL] [Abstract][Full Text] [Related]
60. Comparison of virus production in chicken embryo fibroblasts infected with the WR, IHD-J and MVA strains of vaccinia virus: IHD-J is most efficient in trans-Golgi network wrapping and extracellular enveloped virus release. Meiser A; Boulanger D; Sutter G; Krijnse Locker J J Gen Virol; 2003 Jun; 84(Pt 6):1383-1392. PubMed ID: 12771405 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]